Publikationen
2020
- Simon D., Tascilar K., Krönke G., Kleyer A., Zaiss M., Heppt F., Meder C., Atreya R., Klenske E., Dietrich P., Abdullah A., Kliem T., Corte G., Morf H., Leppkes M., Kremer A., Ramming A., Pachowsky M., Schuch F., Ronneberger M., Kleinert S., Meier C., Hueber A., Manger K., Manger B., Berking C., Tenbusch M., Überla K., Sticherling M., Neurath M., Schett G.:
Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion
In: Nature Communications 11 (2020), Art.Nr.: 3774
ISSN: 2041-1723
DOI: 10.1038/s41467-020-17703-6
- Seitz T., Freese K., Dietrich P., Thasler WE., Boßerhoff AK., Hellerbrand C.:
Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma
In: Scientific Reports 10 (2020), Art.Nr.: 4546
ISSN: 2045-2322
DOI: 10.1038/s41598-020-61510-4
- Jefremow A., Wiesmüller M., Rouse RA., Dietrich P., Kremer A., Waldner M., Neurath M., Siebler J.:
Efficiency and Toxicity of Lenvatinib in Advanced HCC in Later Treatment Lines
In: ONCOLOGY RESEARCH AND TREATMENT, BASEL: 2020
- Dietrich P., Wormser L., Fritz V., Seitz T., de Maria M., Schambony A., Kremer A., Günther C., Itzel T., Thasler WE., Teufel A., Trebicka J., Hartmann A., Neurath M., von Hörsten S., Boßerhoff AK., Hellerbrand C.:
Molecular cross-talk between Y5-receptor and neuropeptide Y drives liver cancer
In: Journal of Clinical Investigation (2020)
ISSN: 0021-9738
DOI: 10.1172/JCI131919
- Linck-Paulus L., Hellerbrand C., Boßerhoff AK., Dietrich P.:
Dissimilar Appearances Are Deceptive-Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma
In: Cells 9 (2020)
ISSN: 2073-4409
DOI: 10.3390/cells9010114
- Koch A., Ebert EV., Seitz T., Dietrich P., Berneburg M., Boßerhoff AK., Hellerbrand C.:
Characterization of glycolysis-related gene expression in malignant melanoma
In: Pathology Research and Practice 216 (2020)
ISSN: 0344-0338
DOI: 10.1016/j.prp.2019.152752
- Dietrich P., Gaza A., Wormser L., Fritz V., Hellerbrand C., Boßerhoff AK.:
Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Is a Novel Prognostic Marker and Contributes to Sorafenib Resistance in Hepatocellular Carcinoma
In: Neoplasia 21 (2019), S. 257-268
ISSN: 1522-8002
DOI: 10.1016/j.neo.2018.11.011
- Dietrich P., Hellerbrand C., Boßerhoff AK.:
The delta subunit of rod-specific photoreceptor cgmp phosphodiesterase (Pde6d) contributes to hepatocellular carcinoma progression
In: Cancers 11 (2019), Art.Nr.: 398
ISSN: 2072-6694
DOI: 10.3390/cancers11030398
- Freese K., Dietrich P., Boßerhoff AK., Hellerbrand C.:
Variation of different histone deacetylases and the functional effects of HDAC inhibitors in hepatocellular carcinoma
International Liver Congress (Vienna, 10. April 2019 - 14. April 2019)
In: JOURNAL OF HEPATOLOGY, AMSTERDAM: 2019
- Freese K., Seitz T., Dietrich P., Lee SM., Thasler WE., Boßerhoff AK., Hellerbrand C.:
Histone deacetylase expressions in hepatocellular carcinoma and functional effects of histone deacetylase inhibitors on liver cancer cells in vitro
In: Cancers 11 (2019), Art.Nr.: 1587
ISSN: 2072-6694
DOI: 10.3390/cancers11101587
- Goeppert B., Truckenmueller F., Ori A., Fritz V., Albrecht T., Fraas A., Scherer D., Silos RG., Sticht C., Gretz N., Mehrabi A., Bewerunge-Hudler M., Pusch S., Bermejo JL., Dietrich P., Schirmacher P., Renner M., Roessler S.:
Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p
In: Scientific Reports 9 (2019)
ISSN: 2045-2322
DOI: 10.1038/s41598-019-40857-3
- Koch A., Ebert EV., Seitz T., Dietrich P., Berneburg M., Boßerhoff AK., Hellerbrand C.:
Characterization of glycolysis-related gene expression in malignant melanoma
In: Pathology Research and Practice (2019), Art.Nr.: 152752
ISSN: 0344-0338
DOI: 10.1016/j.prp.2019.152752
- Mahli A., Seitz T., Beckroege T., Freese K., Thasler WE., Benkert M., Dietrich P., Weiskirchen R., Boßerhoff AK., Hellerbrand C.:
Bone Morphogenetic Protein-8B Expression is Induced in Steatotic Hepatocytes and Promotes Hepatic Steatosis and Inflammation In Vitro
In: Cells 8 (2019)
ISSN: 2073-4409
DOI: 10.3390/cells8050457
- Stieglitz D., Lamm S., Braig S., Feuerer L., Kuphal S., Dietrich P., Arndt S., Echtenacher B., Hellerbrand C., Karrer S., Boßerhoff AK.:
BMP6-induced modulation of the tumor micro-milieu
In: Oncogene 38 (2019), S. 609-621
ISSN: 0950-9232
DOI: 10.1038/s41388-018-0475-x
- Dietrich P., Freese K., Mahli A., Thasler WE., Hellerbrand C., Boßerhoff AK.:
Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic "dual-hit" option
In: Oncotarget 9 (2018), S. 3605-3618
ISSN: 1949-2553
DOI: 10.18632/oncotarget.23188
- Dietrich P., Kuphal S., Spruss T., Hellerbrand C., Boßerhoff AK.:
MicroRNA-622 is a novel mediator of tumorigenicity in melanoma by targeting Kirsten rat sarcoma
In: Pigment Cell & Melanoma Research (2018)
ISSN: 1755-1471
DOI: 10.1111/pcmr.12698
- Schmidt KM., Dietrich P., Hackl C., Guenzle J., Bronsert P., Wagner C., Fichtner-Feigl S., Schlitt HJ., Geissler EK., Hellerbrand C., Lang SA.:
Inhibition of mTORC2/RICTOR Impairs Melanoma Hepatic Metastasis
In: Neoplasia 20 (2018), S. 1198-1208
ISSN: 1522-8002
DOI: 10.1016/j.neo.2018.10.001
- Dietrich P., Boßerhoff AK.:
Melanoma sponge on pigmentation gene to reduce tumour-suppressive microRNAs
In: Pigment Cell & Melanoma Research (2017)
ISSN: 1755-1471
DOI: 10.1111/pcmr.12660
- Dietrich P., Koch A., Fritz V., Hartmann A., Boßerhoff AK., Hellerbrand C.:
Wild type Kirsten rat sarcoma is a novel microRNA-622-regulated therapeutic target for hepatocellular carcinoma and contributes to sorafenib resistance
In: Gut (2017)
ISSN: 0017-5749
DOI: 10.1136/gutjnl-2017-315402
- Dietrich P., Kuphal S., Spruss T., Hellerbrand C., Boßerhoff AK.:
Wild-type KRAS is a novel therapeutic target for melanoma contributing to primary and acquired resistance to BRAF inhibition
In: Oncogene (2017)
ISSN: 0950-9232
DOI: 10.1038/onc.2017.391
- Mahli A., Saugspier M., Koch A., Sommer J., Dietrich P., Lee S., Thasler R., Schulze-Luehrmann J., Lührmann A., Thasler WE., Müller M., Boßerhoff AK., Hellerbrand C.:
ERK activation and autophagy impairment are central mediators of irinotecan-induced steatohepatitis
In: Gut (2017)
ISSN: 0017-5749
DOI: 10.1136/gutjnl-2016-312485
- Dietrich P., Boßerhoff AK.:
Modifying microRNAs--another piece of the melanoma puzzle
In: Pigment Cell & Melanoma Research 28 (2015), S. 488-9
ISSN: 1755-1471
DOI: 10.1111/pcmr.12389
- Hartl J., Dietrich P., Moleda L., Mueller-Schilling M., Wiest R.:
Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension
In: Liver International 35 (2015), S. 2556-63
ISSN: 1478-3223
DOI: 10.1111/liv.12874
- Ruedel A., Dietrich P., Schubert T., Hofmeister S., Hellerbrand C., Boßerhoff AK.:
Expression and function of microRNA-188-5p in activated rheumatoid arthritis synovial fibroblasts
In: International Journal of Clinical and Experimental Pathology 8 (2015), S. 4953-62
ISSN: 1936-2625
